AzTrials
AzTrials

Chronic PainNCT07551687

Pleasant Touch Perception in Persistent Pain.

An observational study of Chronic Pain and Persistent Pain, run by Göteborg University at 1 site in Sweden.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to learn how individuals with chronic pain experience pleasant touch and how often they are exposed to such touch in their daily lives. The study also aims to examine how these experiences relate to pain sensitivity and body awareness. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Pain, Persistent Pain
How many people
100 participants
Where
1 siteSweden
Study dates
26 Apr 2026to 1 Feb 2030
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Adults with persistent pain referred to Smärtteam Västra Götaland for clinical assessment and management.

Who may be able to join

  • Adults aged 18 years and older
  • Referred to and accepted for assessment at Pain Clinic (Smärtteam) Västra Götaland due to persistent pain (duration ≥ 3 months)
  • Able to read and complete self-report questionnaires in Swedish

Who cannot join

  • Inability to read or complete self-report questionnaires in Swedish
  • Need for interpreter support

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Line Löken, PhD contact

+46706722713

line.loken@gu.se

Sweden1 site
  • Smärtteam Västra Götaland

    Gothenburg

Other trials in Sweden

About this study

Official title: Being Touched in Persistent Pain: Mapping the Association Between Pleasant Touch and Central Sensitization in Patients With Persistent Pain.

The goal of this observational study is to learn how individuals with chronic pain experience pleasant touch and how often they are exposed to such touch in their daily lives. The study also aims to examine how these experiences relate to pain sensitivity and body awareness. The main questions it aims to answer are:

How is the perception of pleasant touch associated with central sensitization and interoceptive awareness in individuals with chronic pain?

Read more

Does the perception of pleasant touch differ between individuals with different dominant pain mechanisms (nociceptive, neuropathic, and nociplastic)?

Participants referred to a specialist Pain Clinic in Västra Götaland as part of their regular care will be invited to take part. Those who consent will complete online questionnaires assessing pain, experience and exposure to touch, interoceptive awareness, and central sensitization. Clinical data such as pain diagnosis and medical history will also be collected.

Read the detailed description

This observational study aims to investigate how individuals with chronic pain experience pleasant touch and how these experiences relate to central sensitization, interoceptive awareness, and different pain mechanisms.

Participants referred to the Pain Clinic in Västra Götaland as part of their regular care will be invited to participate. After receiving written and oral information and providing informed consent, participants will complete digital questionnaires via a secure electronic data capture system (REDCap).

The questionnaires assess experience and exposure to pleasant social touch, central sensitization (Central Sensitization Inventory, CSI), interoceptive awareness (Multidimensional Assessment of Interoceptive Awareness, MAIA-2), and pain intensity (Numeric Pain Rating Scale, NPRS). A newly developed questionnaire will be used to assess perception and exposure to social touch, including qualitative components.

Clinical data will be collected during routine physician visits and include pain diagnosis, pain distribution, symptom severity, comorbidities, and medication use. Questionnaire data and clinical data will be linked using participant ID numbers. Treating physicians will not have access to questionnaire responses to reduce the risk of bias.

Additional data may be obtained from the Swedish National Registry for Pain Rehabilitation (NRS), where applicable.

A total of 100 participants will be included. Based on previous registry data and similar studies, subgroup sizes are expected to be sufficient to allow comparisons between individuals with different dominant pain mechanisms (e.g., nociceptive, neuropathic, and nociplastic pain).

Keywords
Nociplastic pain, Neuropathic pain, Nociceptive pain, Pleasant touch, Central sensitization, Interoception, Social touch, Affective touch
Medical subject headings
Chronic Pain, Nociplastic Pain, Neuralgia, Nociceptive Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07551687
Study groupRoleWhat they receive
Chronic Pain PatientsIndividuals with chronic pain referred to a specialist pain clinic in Västra Götaland. Participants will complete questionnaires assessing pain, experience and exposure to pleasant touch, interoceptive awareness, and central sensitization. Clinical data will be collected as part of routine care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Perception of pleasant touch

    Perception of pleasant touch assessed using a study-specific questionnaire measuring experience and exposure to social touch.

    Measured: At baseline

Secondary outcomes (2)
  1. Central sensitization

    Central sensitization measured using the Central Sensitization Inventory (CSI).

    Measured: At baseline

  2. Interoceptive awareness

    Interoceptive awareness assessed using the Multidimensional Assessment of Interoceptive Awareness (MAIA-2).

    Measured: At baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2026
  2. Study start26 Apr 2026 (estimated)
  3. Primary completion1 Feb 2030 (estimated)
  4. Study completion1 Feb 2030 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07551687
Sponsor's protocol ID
2025-08467-01
Other IDs
2025
Status last verified
Mar 2026
First submitted
20 Apr 2026
Last updated
27 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: It is currently undecided whether individual participant data will be shared. Data sharing will be considered in accordance with ethical approvals, data protection regulations, and institutional policies.

Questions about this trial

What is this clinical trial studying?

An observational study of Chronic Pain and Persistent Pain, run by Göteborg University at 1 site in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 27 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Line Löken, PhD (+46706722713, line.loken@gu.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Perception of pleasant touch (time frame: At baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Pleasant Touch Perception in Persistent Pain. | AzTrials